These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 22719190

  • 21. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
    Sikorska K, Stalke P, Romanowski T, Rzepko R, Bielawski KP.
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
    [Abstract] [Full Text] [Related]

  • 22. Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant.
    Jönsson C, Bergram M, Kechagias S, Nasr P, Ekstedt M.
    Scand J Gastroenterol; 2024 Jun; 59(6):737-741. PubMed ID: 38563432
    [Abstract] [Full Text] [Related]

  • 23. Patatin-Like Phospholipase Domain-Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population.
    Unalp-Arida A, Ruhl CE.
    Hepatology; 2020 Mar; 71(3):820-834. PubMed ID: 31705824
    [Abstract] [Full Text] [Related]

  • 24. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study.
    Trunečka P, Míková I, Dlouhá D, Hubáček JA, Honsová E, Kolesár L, Lánská V, Fraňková S, Šperl J, Jirsa M, Poledne R.
    Dig Liver Dis; 2018 May; 50(5):490-495. PubMed ID: 29396131
    [Abstract] [Full Text] [Related]

  • 25. PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations.
    Larrieta-Carrasco E, Acuña-Alonzo V, Velázquez-Cruz R, Barquera-Lozano R, León-Mimila P, Villamil-Ramírez H, Menjivar M, Romero-Hidalgo S, Méndez-Sánchez N, Cárdenas V, Bañuelos-Moreno M, Flores YN, Quiterio M, Salmerón J, Sánchez-Muñoz F, Villarreal-Molina T, Aguilar-Salinas CA, Canizales-Quinteros S.
    Mol Biol Rep; 2014 Jul; 41(7):4705-11. PubMed ID: 24691744
    [Abstract] [Full Text] [Related]

  • 26. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.
    Nischalke HD, Berger C, Luda C, Berg T, Müller T, Grünhage F, Lammert F, Coenen M, Krämer B, Körner C, Vidovic N, Oldenburg J, Nattermann J, Sauerbruch T, Spengler U.
    PLoS One; 2011 Jul; 6(11):e27087. PubMed ID: 22087248
    [Abstract] [Full Text] [Related]

  • 27. Steatosis is a cofactor in liver injury in hemochromatosis.
    Powell EE, Ali A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM, Fletcher LM, Powell LW, Jonsson JR.
    Gastroenterology; 2005 Dec; 129(6):1937-43. PubMed ID: 16344062
    [Abstract] [Full Text] [Related]

  • 28. Association of PNPLA3 I148M with Liver Disease Biomarkers in Latinos.
    Roe JD, Garcia LA, Klimentidis YC, Coletta DK.
    Hum Hered; 2021 Dec; 86(1-4):21-27. PubMed ID: 34749354
    [Abstract] [Full Text] [Related]

  • 29. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E, Fabris C, Cmet S, Cussigh A, Bitetto D, Fontanini E, Fornasiere E, Bignulin S, Fumolo E, Bignulin E, Pirisi M, Toniutto P.
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [Abstract] [Full Text] [Related]

  • 30. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.
    Petit JM, Guiu B, Masson D, Duvillard L, Jooste V, Buffier P, Bouillet B, Brindisi MC, Robin I, Gambert P, Verges B, Cercueil JP, Hillon P.
    Liver Int; 2011 Oct; 31(9):1332-6. PubMed ID: 21745307
    [Abstract] [Full Text] [Related]

  • 31. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
    Sikorska K, Romanowski T, Stalke P, Iżycka-Świeszewska E, Bielawski KP.
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
    [Abstract] [Full Text] [Related]

  • 32. The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients.
    Brouwer WP, van der Meer AJ, Boonstra A, Pas SD, de Knegt RJ, de Man RA, Hansen BE, ten Kate FJ, Janssen HL.
    Liver Int; 2015 Feb; 35(2):438-47. PubMed ID: 25284145
    [Abstract] [Full Text] [Related]

  • 33. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
    Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, NASH CRN.
    Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
    [Abstract] [Full Text] [Related]

  • 34. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
    Romeo S, Sentinelli F, Cambuli VM, Incani M, Congiu T, Matta V, Pilia S, Huang-Doran I, Cossu E, Loche S, Baroni MG.
    J Hepatol; 2010 Aug; 53(2):335-8. PubMed ID: 20546964
    [Abstract] [Full Text] [Related]

  • 35. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP).
    Arslanow A, Stokes CS, Weber SN, Grünhage F, Lammert F, Krawczyk M.
    Liver Int; 2016 Mar; 36(3):418-26. PubMed ID: 26264356
    [Abstract] [Full Text] [Related]

  • 36. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis.
    Finkenstedt A, Auer C, Glodny B, Posch U, Steitzer H, Lanzer G, Pratschke J, Biebl M, Steurer M, Graziadei I, Vogel W, Zoller H.
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1667-72. PubMed ID: 23872669
    [Abstract] [Full Text] [Related]

  • 37. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
    Verrijken A, Beckers S, Francque S, Hilden H, Caron S, Zegers D, Ruppert M, Hubens G, Van Marck E, Michielsen P, Staels B, Taskinen MR, Van Hul W, Van Gaal L.
    Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
    [Abstract] [Full Text] [Related]

  • 38. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
    Petta S, Maida M, Grimaudo S, Pipitone RM, Macaluso FS, Cabibi D, Cammà C, Di Marco V, Sferrazza S, Craxì A.
    Liver Int; 2016 Feb; 36(2):198-204. PubMed ID: 26259026
    [Abstract] [Full Text] [Related]

  • 39. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Sookoian S, Pirola CJ.
    Hepatology; 2011 Jun; 53(6):1883-94. PubMed ID: 21381068
    [Abstract] [Full Text] [Related]

  • 40. Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population.
    Li Y, Xing C, Tian Z, Ku HC.
    BMC Med Genet; 2012 Nov 23; 13():113. PubMed ID: 23176674
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.